Development and Validation of a Pneumocystis jirovecii Real‐time Polymerase Chain Reaction Assay for Diagnosis of Pneumocystis Pneumonia
Open Access
- 1 January 2015
- journal article
- research article
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 26 (5) , 263-267
Abstract
BACKGROUND: Pneumocystis jirovecii (PJ), a pathogenic fungus, causes severe interstitial Pneumocystis pneumonia (PCP) among immunocompromised patients. A laboratory‐developed real‐time polyermase chain reaction (PCR) assay was validated for PJ detection to improve diagnosis of PCP.METHODS: Forty stored bronchoalveolar lavage (BAL) samples (20 known PJ positive [PJ+] and 20 known PJ negative [PJ−]) were initially tested using the molecular assay. Ninety‐two sequentially collected BAL samples were then analyzed using an immunofluorescence assay (IFA) and secondarily tested using the PJ real‐time PCR assay. Discrepant results were resolved by retesting BAL samples using another real‐time PCR assay with a different target. PJ real‐time PCR assay performance was compared with the existing gold standard (ie, IFA) and a modified gold standard, in which a true positive was defined as a sample that tested positive in two of three methods in a patient suspected to have PCP.RESULTS: Ninety of 132 (68%) BAL fluid samples were collected from immunocompromised patients. Thirteen of 92 (14%) BALs collected were PJ+ when tested using IFA. A total of 40 BAL samples were PJ+ in the present study including: all IFA positive samples (n=13); all referred PJ+ BAL samples (n=20); and seven additional BAL samples that were IFA negative, but positive using the modified gold standard. Compared with IFA, the PJ real‐time PCR had sensitivity, specificity, and positive and negative predictive values of 100%, 91%, 65% and 100%, respectively. Compared with the modified gold standard, PJ real‐time PCR had a sensitivity, specificity, and positive and negative predictive values of 100%.CONCLUSION: PJ real‐time PCR improved detection of PJ in immunocompromised patients.Keywords
This publication has 35 references indexed in Scilit:
- Use of real-time polymerase chain reaction for the diagnosis of Pneumocystis pneumonia in immunocompromised patients: a meta-analysisChinese Medical Journal, 2013
- Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infectionJournal of Infection and Chemotherapy, 2012
- Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificityDiagnostic Microbiology and Infectious Disease, 2011
- Trends in Hospitalizations for AIDS-Associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005)Chest, 2009
- Evolving Health Effects of PneumocystisJAMA, 2009
- A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluidDiagnostic Microbiology and Infectious Disease, 2006
- Pneumocystis and Trypanosoma cruzi: Nomenclature and TypificationsJournal of Eukaryotic Microbiology, 2006
- Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and bloodThe Lancet, 1992
- Detection of Pneumocystis carinii DNA by polymerase chain reaction compared to direct microscopy and immunofluorescence.1991
- DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumoniaThe Lancet, 1991